Furthermore, IDH1 mutation was an important classification biomarker for glioma 29, The IHC results showed that compared with the IDH1-MT, the expression levels of TRIM21 and β-catenin are significantly upregulated but TIF1γ decreased in IDH1-WT glioma (Figure 7A-D). The gene discussed is IDH1; the disease is central nervous system cancer.